Biological computing becomes interesting before 2031?
Data is not live — latest snapshot Aug 12, 3:19 PM ET
Too little market data to assess this move — treat the probability with caution.
This venue reports too little volume or book data for this market to judge the trading behind the price.
How credible was the move?
Three separate questions — a move can be genuine while the latest price is still settling. Methodology →
Move validity
Is the move backed by real trading and depth?
Insufficient dataThis venue reports too little volume or book data for this market to judge the trading behind the price.
Consensus stability
Has the market settled at the new probability?
StableThe probability has held near its current level over the past several hours.
Contract clarity
Will the rules resolve without ambiguity?
HighThe resolution rules are relatively specific, with a named source and a defined deadline.
From the latest trade tape (most recent 200 prints) — a live activity sample, not a lifetime total.
What this market actually measures
Resolves YES if, before January 1, 2031, a credible report shows that a company earned >= $50M USD in revenue attributable to biological-computing products or services in a year. Note: A year = Over a fiscal year or over any trailing 12-month period of actual (not projected or run rate) revenue.
This summary shows the opening of the venue's official rules. ProbCast has not yet generated an independent plain-English interpretation for this contract — review the full rules before relying on it.
View full official resolution rules
Resolves YES if, before January 1, 2031, a credible report shows that a company earned >= $50M USD in revenue attributable to biological-computing products or services in a year. Note: A year = Over a fiscal year or over any trailing 12-month period of actual (not projected or run rate) revenue. Report must be published before Jan 1, 2031. (e.g. FY2030 report released in early 2031 does not count). Resolves NO if January 1, 2031 passes with no such report. For a company whose primary business is biological computing, total company revenue counts. For any other company, only the segment it explicitly discloses as biological-computing revenue counts. What count as biological computing: living-neuron/organoid systems (e.g. Cortical Labs, FinalSpark). What doesn't count: DNA/molecular data storage, synthetic biology logic circuits used purely as biosensors, and neuromorphic silicon chips.
What could move this market next?
- The market's deadline arrivesDecember 31, 2030 at 6:59 PM ET
The contract must resolve based on what has happened by this date.
Derived from the contract's own mechanics as of Aug 12, 3:41 PM ET. ProbCast does not list scheduled meetings, announcements, or data releases it cannot verify.
Advanced analysis (experimental)
Research signals — these models are still accumulating the history needed for full validation, and they can disagree with the headline read. Model confidence: low · expected error ±21 pts.
What's happening
Thin book and/or wide spread. Small orders can move this price disproportionately, so any single print is noisy and easily overread.
Market data
24h volume
Ṁ0
Liquidity
Ṁ250
Total volume
Ṁ226.1